SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001599298-19-000017
Filing Date
2019-10-11
Accepted
2019-10-11 07:44:28
Documents
61
Period of Report
2019-07-31

Document Format Files

Seq Description Document Type Size
1 6-K a6-kq2july2019xfrontpage.htm 6-K 31366
2 EXHIBIT 99.1 rns-q2july2019.htm EX-99.1 745964
3 EXHIBIT 99.2 ias34-q2july2019.htm EX-99.2 809997
10 summitmasterrgbjpeg.jpg GRAPHIC 65667
  Complete submission text file 0001599298-19-000017.txt   5957017

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT smmt-20190731.xml EX-101.INS 1304077
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20190731.xsd EX-101.SCH 43653
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20190731_cal.xml EX-101.CAL 67730
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20190731_def.xml EX-101.DEF 136039
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20190731_lab.xml EX-101.LAB 458547
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20190731_pre.xml EX-101.PRE 259488
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 001-36866 | Film No.: 191147031
SIC: 2834 Pharmaceutical Preparations